IMR Press / EJGO / Volume 22 / Issue 1 / pii/2001110

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Advanced primary carcinoma of the Bartholin gland: Report of 18 patients

Show Less
1 Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Gaziantep, Sahinbey Medial Center, Gaziantep, Turkey
2 Department of Gynecologic Oncology; the University of Texas, M.D., Anderson Cancer Center, Houston, Texas, USA
3 Department of Radiotherapy, the University of Texas, M.D., Anderson Cancer Center, Houston, Texas, USA
Eur. J. Gynaecol. Oncol. 2001, 22(1), 46–49;
Published: 10 February 2001

Conservative surgery plus radiotherapy for vulvar cancer has been established as a therapeutic alternative to extensive radical surgery and produces a similar cumulative 5-year survival. We retrospectively analyzed the cases of 18 patient、 with advanced primary carcinoma of the Bartholin gland treated with wide local excision (WLE) or radical vulvectomy and lymphadenectomy fol­lowed by radiotherapy (RT) at the University of Texas M. D. Anderson Cancer Center from January 1978 through December 1990. All patients have been observed for a minimum of 7 months (maximum follow-up, 15 years; median follow-up, 9 years). Of the 18 patients, 7 were treated with wide local excision (WLE) followed by radiation therapy (RT) (Group I), 9 had radical vulvectomy (RV) followed by RT to the vulvar and inguinal-femoral and pelvic node areas (Group II), and 2 were treated with RT alone after biopsy of the tumor (Group III). The 5-year disease-free survival rates were 86%, 78%, and 50% for groups I, II, and Ill, respectively, and 83% for the whole group. Of 2 patients treated with RT alone, one lived for 6 years with no evidence of disease, and the other lived for 20 months. The rate of local tumor control was 100% for all three treatment groups. There were no significant differences among the treatment groups in rate of primary tumor control or 5-year disease-free survival rate (p = 0.1300). The present study demonstrated WLE followed by RT is the best treatment for advanced primary carcinoma of the Bartholin gland. Less radical surgery plus RT produces good long-term survival and has fewer complications.

Bartholin gland carcinoma
Radical vulvectomy
Wide local excision
Back to top